Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Radiotherapy

Clinical trial NCT07005882 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07005882
Sponsor: Azienda Ospedaliero-Universitaria Careggi
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Patients Breast Cancer Early Stage Breast Cancer (Stage 1-3)HR+/HER2- Breast Cancer Radiation Therapy

Start date: 2025-09-01
Primary completion: 2027-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.